A new publication reveals superior clinical performance and a statistically significant reduction in staple line bleeding when using AEON™ in Roux-en-Y gastric bypass procedures. Both AEON™ and leading competitor were found to be safe and effective with low complication rates and comparable clinical performance in sleeve gastrectomy and single anastomosis duodenoileostomy with gastric sleeve procedures.
The study represents the largest patient cohort ever examined AEON™, with a total sample size of 1,848 patients.
